Entities / Company
Molecular Partners.
biopharmaceutical company based in Zürich, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 15
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Molecular Partners this week
News at the entities that move Molecular Partners most-
TD Cowen Mentioned togetherTD Cowen, Bank of America, UBS and Scotiabank issued ratings and raised price targets for Johnson & Johnson on November 21, 2026.Moves Molecular Partners
-
Novartis OperationalGenScript's Ray Chen, Lundbeck's CEO, and Isomorphic Labs' Hassabis discuss AI partnerships in drug development, including Isomorphic's Novartis deal.Moves Molecular Partners
-
Switzerland Shared contextSeveral individuals, including Jean-Pierre Gallati and Franz Ruppen, are candidates for the Swiss Federal Council, and Guy Parmelin is replacing a minister.Moves Molecular Partners
-
Zurich Shared contextMarsh groups Australia and New Zealand in the South Pacific, noting Zurich's operations in Australia.Moves Molecular Partners
-
Nasdaq Shared contextJensen Huang's company is noted as a major component of the Nasdaq exchange.Moves Molecular Partners
Connections
The 8 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Patrick Amstutz Structural
Patrick Amstutz serves as the Chief Executive Officer of Molecular Partners.
-
TD Cowen Mentioned together
TD Cowen provides analyst coverage and buy ratings for Molecular Partners.
-
Switzerland Shared context
Molecular Partners is a biotech company operating and based in Switzerland.
-
Zurich Shared context
Molecular Partners maintains its operational headquarters and offices within the city of Zurich.
-
Novartis Operational
Molecular Partners and Novartis maintain an active partnership relationship.
-
Nasdaq Shared context
Molecular Partners is listed on the Nasdaq exchange.
-
Concord Shared context
Molecular Partners maintains offices and operations within Concord, MA.
-
Schlieren Shared context
Molecular Partners is headquartered in Schlieren.
History
Events by the month they beganAugust 2026
1 eventJune 2026
3 events- Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.
- Analyst firm TD Cowen issued buy ratings for Molecular Partners, a company based in Switzerland.
- Molecular Partners and Orano Med formed a strategic partnership to co-develop the MP0726 candidate.